Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Stephen V. Liu is an Assistant Professor of Medicine and a practicing thoracic medical oncologist at the Lombardi Comprehensive Cancer Center at Georgetown University. He received his undergraduate degree at Johns Hopkins University and his medical degree at the University of Maryland. He then completed his internship and residency in Internal Medicine at the University of Pennsylvania and his fellowship training in Hematology and Oncology at the University of Southern California before joining the faculty of Georgetown University. Dr.

Targeted Therapies Forum Presented in English 2023 - Breakout Sessions 2
Our Targeted Therapies Forum online event includes a Q&A session where our amazing faculty answers questions from the audience. This is the second batch of videos of the Breakout Sessions.
Author
Stephen Liu, MD, GRACE Faculty
Image
Targeted Therapies Forum presented in English

This series includes videos from the breakout sessions presented by Dr. Stephen Liu, including the following topics:

  • Safety and Toxicity of Selpercatinib Versus Pralsetinib
  • The Future of RET+ NSCLC Treatment
  • NTRK+ NSCLC: Treatment Options and Side Effects
  • NRG1 Fusions: Treatment Options

To watch the complete playlist click here.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora